HARRINGTON R W, PALLETTE E C, PALLETTE E M
Calif Med. 1962 Jun;96(6):384-7.
In 29 consecutive cases of resection and aortic homograft replacement done between 1954 and 1958, the only surgical mortality occurred 14 days postoperatively and was due to a rupture of the implanted vessel.Seven patients have died (after a survival time averaging 21 months postoperatively) of causes not directly related to the aortic disease or to the operation.Twenty-one patients were still living some three to six and a half years after the implantation procedure-all of them active and showing no clinical evidence of aneurysmal dilatation. Infant thoracic aorta was used for homograft in the femoropopliteal area in three cases. Two of the patients were still living at the time of last report, four and five years after operation, with no evidence of obstruction or dilatation. This is perhaps indicative of the superiority of this material over plastic prosthesis for this purpose.
在1954年至1958年间连续进行的29例切除及主动脉同种异体移植手术中,仅1例手术死亡发生在术后14天,原因是植入血管破裂。7例患者(术后平均存活21个月)死于与主动脉疾病或手术无直接关联的原因。21例患者在植入手术后约三至六年半仍存活,他们均活动自如,且无动脉瘤扩张的临床证据。3例患者在股腘区域使用婴儿胸主动脉进行同种异体移植。截至上次报告时,其中2例患者仍存活,分别在术后四年和五年,无梗阻或扩张迹象。这或许表明在此用途上,这种材料优于塑料假体。